|
|
||||||||
Interdisciplinary Center for Clinical Research (IZKF) BIOMAT, RWTH Aachen University Hospital, Pauwelsstr. 30, D-52074 Aachen, Germany
1 Division of Nephrology and Immunology, RWTH Aachen University Hospital, Pauwelsstr. 30, D-52074 Aachen, Germany
(Requests for offprints should be addressed to M Wöltje; Email: woeltje{at}rwth-aachen.de)
Alpha2HS-glycoprotein/fetuin-A (Ahsg) is a serum protein preventing soft tissue calcification. In trauma and inflammation, Ahsg is down-regulated and therefore considered a negative acute phase protein. Enhancement of Ahsg expression as a protective serum protein is desirable in several diseases including tissue remodelling after trauma and infection, kidney and heart failure, and cancer. Using reporter gene assays in hepatoma cells combined with electrophoretic mobility shift assays we determined that dexamethasone up-regulates hepatic Ahsg. A steroid response unit at position 146/119 within the mouse Ahsg promoter mediates the glucocorticoid-induced increase of Ahsg mRNA. It binds the hepatocyte nuclear factor 3ß and CCAAT enhancer binding protein ß (C/EBP-ß). The up-regulation is mediated indirectly via glucocorticoid hormone-induced transcriptional up-regulation in C/EBP-ß protein. A high degree of sequence identity in mouse, rat and human Ahsg promoters suggests that the promoter is similarly up-regulated by dexamethasone in all three species. Therefore, our findings suggest that glucocorticoids may be used to enhance the level of Ahsg protein circulating in serum.
This article has been cited by other articles:
![]() |
J.-S. Shao, S.-L. Cheng, J. Sadhu, and D. A. Towler Inflammation and the Osteogenic Regulation of Vascular Calcification: A Review and Perspective Hypertension, March 1, 2010; 55(3): 579 - 592. [Full Text] [PDF] |
||||
![]() |
S. Sai, C. L. Esteves, V. Kelly, Z. Michailidou, K. Anderson, A. P. Coll, Y. Nakagawa, T. Ohzeki, J. R. Seckl, and K. E. Chapman Glucocorticoid Regulation of the Promoter of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Is Indirect and Requires CCAAT/Enhancer-Binding Protein-{beta} Mol. Endocrinol., September 1, 2008; 22(9): 2049 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heiss, T. Eckert, A. Aretz, W. Richtering, W. van Dorp, C. Schafer, and W. Jahnen-Dechent Hierarchical Role of Fetuin-A and Acidic Serum Proteins in the Formation and Stabilization of Calcium Phosphate Particles J. Biol. Chem., May 23, 2008; 283(21): 14815 - 14825. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Petrik, S. Saadoun, A. Loosemore, J. Hobbs, K. S. Opstad, J. Sheldon, E. Tarelli, F. A. Howe, B. A. Bell, and M. C. Papadopoulos Serum {alpha}2-HS Glycoprotein Predicts Survival in Patients with Glioblastoma Clin. Chem., April 1, 2008; 54(4): 713 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, C. Guo, P. Zhu, W. Li, L. Myatt, and K. Sun Role of glucocorticoid receptor and CCAAT/enhancer-binding protein {alpha} in the feed-forward induction of 11{beta}-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts J. Endocrinol., November 1, 2007; 195(2): 241 - 253. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |